Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

Authors
Publication date
6 March 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    İstanbul Üniversitesi Açık Erişim Sistemi

    redirect
    oaioai:http://acikerisim.istanbul...
    Last time updated on 19/10/2022